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Summary
Objective: This cross-sectional study compares the rela-
tionship of visceral and total abdominal adipose tissue 
(VAT and TAAT) measurements obtained with magnetic 
resonance imaging (MRI) and a range of ‘simpler’ tech-
niques suitable for field or bedside use: BMI, waist cir-
cumference (WC), bioelectrical impedance (BIA) devices 
and dual X-ray absorptiometry (DXA). Method: 120 par-
ticipants were recruited, stratified by gender and BMI 
(20 men and 20 women within each group: lean, over-
weight and obese). Measurements included height, 
weight, WC (at midpoint), DXA L2-L4 fat, and BIA (two 
whole-body and one abdominal device). MRI was used 
as the reference. Results: MRI data showed that men 
have more VAT than women, (mean 147 vs. 93 cm2) de-
spite less TAAT (362 vs. 405 cm2). Correlations of simpler 
abdominal fat measures showed significantly higher cor-
relations with TAAT than with VAT in men and women. 
Similarly, trunk and whole-body fat measures were sig-
nificantly more strongly correlated with TAAT than with 
VAT. Conclusion: None of the simpler techniques show 
strong correlations with VAT measured by MRI, but WC, 
abdominal BIA ‘visceral fat level’ and DXA L2-L4 fat all 
show similar and strong correlations with TAAT and 
may be useful in large scale surveys. 
Introduction
Abdominal adipose tissue can be measured accurately using 
well-established imaging techniques such as computed tomog-
raphy (CT) and magnetic resonance imaging (MRI) [1, 2]. 
Both techniques are able to differentiate between and quantify 
subcutaneous abdominal adipose tissue (SAAT) and visceral 
adipose tissue (VAT) depots. These imaging techniques have 
been used to demonstrate the relationship between abdominal 
obesity and morbidity [3, 4] and premature mortality [5]. 
Quantifying abdominal adipose tissue to assess clinical risk 
in studies of obesity and disease is challenging. Because of 
ionising radiation risks, it is inappropriate to measure abdom-
inal fat with CT in many research and clinical situations. MRI, 
while low risk, requires specialised resources and is relatively 
expensive for measurements of fat distribution alone.
Many more simple clinical measurements are available 
which may serve as useful proxies for abdominal fat. BMI, an 
index of whole-body weight, and waist circumference (WC), 
an index of abdominal size, are established proxy measures 
for adiposity and have shown good correlations with abdomi-
nal fat measures from CT and MRI [6, 7]. Such measurements 
have also demonstrated important relationships with morbid-
ity [8–11] and premature mortality [12] and are used clinically 
to assess health risks [13]. 
Other techniques available include whole-body bioelectri-
cal impedance (BIA) devices that predict total and regional 
body adiposity from gender-specific equations using a combi-
nation of weight, height and BIA measures. A new abdominal 
BIA device has recently been developed to measure and use 
WC and BIA results to estimate abdominal adiposity from 
gender-specific equations. Dual X-ray absorptiometry (DXA), 
while a more expensive and time-consuming technique than 
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either BIA or the manual measurements, is able to differenti-
ate lean and fat tissue, from a 2-D low energy X-ray. It has 
been suggested to be a low-risk, quicker and cheaper tech-
nique than CT or MRI to quantify whole-body and regional 
adipose tissue distribution [14–16]. 
Objectives
This study explores the relationships between the available 
simpler techniques (BMI, WC, BIA, and DXA), measuring 
abdominal, trunk and whole-body fat, with VAT, SAAT and 
total abdominal adipose tissue (TAAT) measures from MRI. 
Material and Methods
Study Design
The study was approved by the Local Research Ethics Committee (08/
H0306/64). Participants gave written, informed consent before inclusion 
in the study. The study had a cross-sectional design, with each participant 
completing two study visits within 7 days. On the first visit, at MRC 
Human Nutrition Research, all anthropometry, BIA and DXA measure-
ments were made. On the second visit, at the MRIS Unit at Adden-
brookes Hospital, the MRI was performed. 
Recruitment
120 participants, aged between 18 and 79 years were recruited into one of 
6 groups, stratified by gender and BMI (<25, 25–29.9 and 30–35 kg/m2, or 
lean, overweight and obese groups). Exclusion criteria were designed to 
exclude subjects for whom the MRI or BIA was unsuitable and for whom 
results may be unreliable due to unusual changes in body weight or com-
position. Participants were excluded if they were not weight stable (de-
fined as a self-reported weight change of more than 2 kg in the previous 
month), were pregnant or lactating women, were athletes, had been pre-
viously diagnosed with lipodystrophy, had any disorder or concomitant 
medication known to affect fat distribution, experienced cancer within 
last 5 years, or had been treated with surgical aneurysm clips in the brain, 
inner ear implants, replacement joints, prosthetic limbs, metal implants or 
a pacemaker. 
Anthropometry
Height was measured using a wall-mounted stadiometer (Holtain Ltd, 
Dyfed, Wales, UK), to the nearest 0.5 cm, with the participant’s head in 
the Frankfort plane. Body mass, wearing light indoor clothing but no 
shoes, was measured using a whole-body BIA device, the BC-420 MA 
(Tanita Corp, Tokyo, Japan), to the nearest 0.1 kg. A correction factor of 
–1 kg was used to adjust for the weight of clothes. WC was measured 
using a tape measure to the nearest 0.5 cm at both the level of the umbili-
cus and the level of the midpoint waist, as defined by the World Health 
Organisation, by measuring at the mid-point between the lowest palpable 
rib and the top of the iliac crest, in the mid-axillary line. The WC meas-
urements within a participant were taken in triplicate by the same trained 
observer, repositioning the tape between measurements, with the average 
at each level taken and reported. 
Abdominal BIA
For the first 13 participants the AB-100 (Tanita Corp) was used, for the 
remaining 107 participants the AB-140 was used (Tanita Corp). The two 
devices differ cosmetically but use the same core components. For all ab-
dominal BIA measurements, participants were in a supine position, with-
out a pillow, with arms laid across the chest. The device was positioned 
perpendicularly to the participant’s body at the umbilical level according 
to the  manufacturers’ instructions, with the multi-frequency electrode 
device positioned on the abdomen in direct contact with the skin. Trunk 
fat% and ‘visceral fat level’ measurements were made in triplicate, repo-
sitioning the device between each measurement. The average of the 
 triplicate results was used to compare with the MRI results. 
Whole-Body BIA
Two whole-body BIA devices were used to estimate body composition, 
the BC-420 and the MC-180 (Tanita Corp), recording data using an ano-
nymised record in the GMON Customer Administration programme. 
The BC-420 MA measures total body composition based on the leg-to-leg 
impedance technique, while the MC-180 MA measures compartmental 
composition based on a multi-compartmental impedance technique. 
Height (cm) was entered into both devices which measured body mass 
and impedance and calculated fat mass (kg), lean mass (kg) and bone 
mass (kg) in the whole body or in specific regions. All measurements 
were made in triplicate, and the average value was used in data analysis. 
DXA
Whole-body DXA was performed using a Lunar MD with software 4.7e 
(GE Lunar Corporation, Madison, WI, USA). For sagittal diameters be-
tween 13 and 25 cm the standard mode was used, and for diameters 
greater than 25 cm the thick mode was used. Participants removed all 
outer clothing, and were measured wearing underwear and a dressing 
gown. Scans were analysed using standard Encore software to estimate 
fat, fat-free mass and bone mass. Two regions of interest were defined: 
abdominal, as the region marked by vertebrae L2-L4, and trunk, as the 
whole-body minus limbs and head. The two regions of interest were iden-
tified on each individual scan by a trained observer.
Abdominal MRI
Participants were each examined once at 1.5T (HDx, GE Healthcare, 
Waukesha, WI, USA) using an 8-channel torso-phased array coil, and 
analysed with SliceOmatic, version 4.3 software, licensed by TomoVision 
(TomoVision, Montreal, QC, Canada). A single shot fast spin echo 
(SSFSE) sequence was applied with the following parameters: TE / TR / 
BW / matrix size / FOV (minfull / min / 62.5 KHz / 256 × 256 / 32–48 cm). 
The field of view was set to encompass both VAT and SAAT. The slice 
thickness was 10 mm with a 5 mm inter-slice gap. Slices were obtained 
from the level of the xiphisternum to the pubic symphysis. For measure-
ment of VAT and SAAT area in the abdominal region, the single slice 
selected for analysis was in line with the iliac crests at the L4/5 vertebrae, 
a commonly selected slice close to the umbilicus, previously shown to be 
correlated with multi-slice VAT and SAAT volumes [17]. VAT and 
SAAT areas were identified by an experienced trained technician with 
5 years experience in quantifying abdominal adipose tissue; each assess-
ment was agreed in consensus with a radiologist with over 20 years expe-
rience in adipose tissue quantification. VAT and SAAT areas were 
summed to give the TAAT area.
Statistical Analysis
Raw data was checked and analysed by an independent statistician. Pear-
son’s correlation coefficients with 95% confidence intervals were calcu-
lated to determine the relationship between different simpler measures and 
the MRI measures. Linear regression was used to separate the effects of 
the simpler measures in their relationships with MRI measures. All analy-
sis was performed using SPSS version 16 (SPSS Inc, Chicago, IL, USA).
Results
Table 1 shows the characteristics of the participants by gender 
and BMI group. The design, with stratification by BMI, 
achieved a similar mean and spread of BMI in men and 
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with VAT, SAAT, and TAAT. In general, correlations tended 
to be highest with TAAT, followed by SAAT, and are lowest 
with VAT. Almost all simpler techniques were significantly 
better correlated with TAAT than with VAT in both men and 
women. 
Comparing the abdominal fat measures, four of the meas-
ures, DXA L2-L4, WC (midpoint and umbilical) and abdomi-
nal BIA ‘visceral fat level’, were all similarly correlated in 
both men and women with each of the three MRI outcomes: 
VAT, SAAT, and TAAT (table 2, fig. 3). All four of these 
variables in men and three of four (not umbilical WC) in 
women showed significantly higher correlations with TAAT 
than with VAT (table 2). Abdominal BIA ‘visceral fat level’ 
from the specific abdominal fat BIA device showed a signifi-
cantly higher correlation with SAAT in men and women, and 
with TAAT in women, than with the ‘visceral fat level’ from 
women. The stratification also achieved a broad range of 
VAT values in men and women (fig. 1). Men tended to have 
more VAT than women, (mean 147 vs. 93 cm2) and a greater 
spread of VAT values (SD 85 vs. 46 cm2). Figure 2 shows the 
distribution of individual TAAT values of participants in each 
gender and BMI group. There was less difference between 
men and women for TAAT than for VAT. Men tended to 
have slightly lower TAAT values than women (mean 362 vs. 
405 cm2). Differences in SAAT were similar to TAAT, with 
men tending to have lower SAAT than women (mean 215 vs. 
312 cm2). 
Table 1 shows an absolute difference in WC measurements 
at two commonly reported sites. The mean difference be-
tween the two WC measurements was 0.3 cm in men and 
4.1 cm in women and was similar across the three BMI groups.
Relationship between Total Abdominal and Visceral Adipose 
Tissue
Data from MRI (table 2) showed that, while VAT and TAAT 
are correlated, they are not directly proportional (0.77 and 
0.65 in men and women respectively). In contrast, SAAT and 
TAAT tend to be more highly correlated, especially in women 
(0.86 and 0.95 in men and women respectively). The corre-
lation of SAAT with TAAT is significantly higher than the 
correlation of SAAT with VAT in both men and women. 
Relationship between Simpler Indices and MRI VAT, SAAT 
and TAAT
Results in table 2 show that all simple indices of whole-body 
fat, abdominal fat, and trunk fat are significantly correlated 
Table 1. Descriptive characteristics of the participants
Male Female
Abdominal fat
MRI TAAT, cm2 362 (155) 405 (134)
MRI VAT, cm2 147 (85)  93 (46)
MRI SAAT, cm2 215 (104) 312 (110)
DXA L2-L4 fat, %  36.1 (11.4)  47.0 (8.2)
Midpoint WC, cm 101.3 (12.3)  93.4 (11.7)
Umbilical WC, cm 101.6 (12.1)  97.5 (12.4)
Abdominal BIA ‘visceral fat level’  13.6 (5.5)   9.5 (3.2)
BC-420 ‘visceral fat level’  12.6 (5.1)   8.8 (3.0)
MC-180 ‘visceral fat level’  11.8 (4.8)   8.4 (2.9)
Trunk fat
DXA trunk fat, %  32.2 (10.4)  43.2 (7.6)
Abdominal BIA trunk fat, %  28.6 (8.3)  42.1 (7.6)
MC-180 trunk fat, %  23.4 (8.1)  31.5 (5.6)
Whole-body fat
BMI, kg/m2  27.5 (4.4)  27.4 (4.1)
DXA whole-body fat, %  27.8 (8.7)  42.8 (6.6)
BC-420 whole-body fat, %  24.0 (7.2)  37.4 (5.6)
MC-180 whole-body fat, %  22.2 (6.9)  35.5 (5.0)
Data presented as mean (SD). 
Fig. 1. Distribution of individual VAT values, divided by gender and 
BMI groups.
Fig. 2. Distribution of individual TAAT values, divided by gender and 
BMI groups.
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To separate the relationship between the simpler indices of 
whole-body and abdominal fat, linear regression was per-
formed. Results showed that adding BMI into models for cor-
relating abdominal BIA ‘visceral fat level’ and DXA L2-L4 
fat with MRI TAAT, improved the R, with both independent 
variables remaining significant (R for model was 0.96 or 0.95 
in men and 0.95 or 0.94 for women respectively). Adding BMI 
to the model for midpoint WC did not improve the R for the 
model for men (0.96), but increased it slightly for women 
(from 0.91 to 0.94). 
either of the two whole-body BIA devices (BC-420 and 
MC-180) (table 2). 
All three trunk fat measures were highly correlated with 
TAAT in men, but the whole-body BIA devices showed a sig-
nificantly lower correlation with TAAT than either DXA 
trunk fat or abdominal BIA trunk fat in women (table 2). 
Comparing the four whole-body fat measures, all were well 
correlated with TAAT in men, while in women BMI tended 
to show higher correlations (though not significantly higher) 
than DXA and whole-body BIA (table 2). 
Table 2. Pearson’s correlation coefficients between results from the MRI, with simpler techniques (manual, BIA and DXA) to measure abdominal, 
trunk and whole-body fat
Male Female
MRI VAT MRI SAAT MRI TAAT MRI VAT MRI SAAT MRI TAAT
Abdominal fat
MRI VAT, cm2 1.00 0.33 
(0.08–0.54)
0.77 
(0.64–0.85)
1.00 0.37 
(0.13–0.57)
0.65 
(0.47–0.77)
MRI SAAT, cm2 0.33 
(0.08–0.54)
1.00 0.86 
(0.77–0.91)*
0.37 
(0.13–0.57)
1.00 0.95 
(0.92–0.97)*#†
MRI TAAT, cm2 0.77 
(0.64–0.85)
0.86 
(0.77–0.91)
1.00 0.65 
(0.47–0.77)
0.95 
(0.92–0.97)*#†
1.00
DXA L2-L4 fat, % 0.70 
(0.54–0.81)
0.77 
(0.64–0.85)
0.90 
(0.83–0.94)*
0.62 
(0.43–0.75)
0.83 
(0.73–0.89)#†
0.90 
(0.83–0.94)*#†
Midpoint WC, cm 0.75 
(0.61–0.84)
0.82 
(0.71–0.89)
0.96 
(0.93–0.97)*#
0.75 
(0.61–0.84)
0.80 
(0.68–0.87)#†
0.91 
(0.85–0.94)*#†
Umbilical WC, cm 0.71 
(0.55–0.81)
0.85 
(0.76–0.90)
0.96 
(0.93–0.97)*#
0.74 
(0.60–0.84)
0.76 
(0.63–0.85)†
0.88 
(0.80–0.92) #†
Abdominal BIA  
‘visceral fat level’
0.65 
(0.47–0.77)
0.87 
(0.79–0.92)*#†
0.94 
(0.90–0.96)*
0.64 
(0.46–0.77)
0.86 
(0.77–0.91)*#†
0.92 
(0.87–0.95)*#†
BC-420  
‘visceral fat level’
0.80 
(0.68–0.87)
0.64 
(0.46–0.77)
0.87 
(0.79–0.92)
0.64 
(0.46–0.77)
0.47 
(0.25–0.65)
0.61 
(0.42–0.74)
MC-180  
‘visceral fat level’
0.82 
(0.71–0.89)
0.67 
(0.50–0.79)
0.90 
(0.83–0.94)
0.61 
(0.42–0.74)
0.45 
(0.22–0.63)
0.58 
(0.38–0.73)
Trunk fat
DXA trunk fat,  
%
0.69 
(0.53–0.80)
0.77 
(0.64–0.85)
0.89 
(0.82–0.93)*
0.63 
(0.44–0.77)
0.82 
(0.71–0.89)
0.89 
(0.82–0.93)*
AB-140 trunk fat,  
%
0.65 
(0.47–0.77)
0.85 
(0.76–0.90)
0.93 
(0.88–0.95)*
0.61 
(0.42–0.74)
0.83 
(0.73–0.89)
0.89 
(0.82–0.93)*
MC-180 trunk fat,  
%
0.64 
(0.46–0.77)
0.80 
(0.68–0.87)
0.89 
(0.82–0.93)*
0.81 
(0.70–0.88)
0.65 
(0.47–0.77)
0.71 
(0.55–0.81)
Whole-body fat
BMI, kg/m2 0.64 
(0.46–0.77)
0.84 
(0.74–0.90)
0.92 
(0.87–0.95)*
0.58 
(0.38–0.73)
0.86 
(0.77–0.91)*
0.91 
(0.85–0.94)*
DXA whole-body fat,  
%
0.65 
(0.47–0.77)
0.80 
(0.68–0.87)
0.89 
(0.82–0.93)*
0.52 
(0.30–0.68)
0.80 
(0.68–0.87)*
0.84(0.74–0.90)*
BC-420 whole-body fat,  
%
0.71 
(0.55–0.81)
0.76 
(0.63–0.85)
0.90 
(0.83–0.94)*
0.65 
(0.47–0.77)
0.71 
(0.55–0.81)
0.81 
(0.70–0.88)
MC-180 whole-body fat,  
%
0.69 
(0.53–0.80)
0.80 
(0.68–0.87)
0.92 
(0.87–0.95)*
0.61 
(0.42–0.74)
0.71 
(0.55–0.81)
0.80 
(0.68–0.87)
Data presented as Pearson’s correlation coefficient (95% CI). 
*Significantly different from correlation of same simpler variable with VAT. 
#Significantly different from correlation with BC-420 ‘visceral fat level’ within gender 
†Significantly different from correlation with MC-180 ‘visceral fat level’ within gender.
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Fig. 3. Scatter plots 
of the relationship 
between MRI total 
abdominal adipose 
tissue (TAAT) and 
simpler measures of 
abdominal fat:  
a DXA L2-L4 fat, 
b midpoint WC, 
c umbilical WC and 
d Abdominal BIA 
‘visceral fat level’.
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adipose tissue areas, suggesting that both are useful proxy 
measures for TAAT. Importantly, both WC measures are bet-
ter correlates of TAAT than of VAT. A previous study has 
suggested that the site of measurement of WC does not mat-
ter for its ability to predict disease [25]. 
The strong correlation between BMI and TAAT in this 
study was unexpected and may simply reflect the fact that as 
whole-body fat increases so too does abdominal fat. However, 
the linear regression results suggest that the simpler measures 
of whole-body fat and abdominal fat do have independent 
 relationships with TAAT. Further, strong correlations with 
TAAT do not necessarily transfer to their usefulness as pre-
dictors of disease, and it is known from other cross-sectional 
and prospective studies that the BMI and WC have independ-
ent relationships with obesity-related disease. 
Conclusion 
Simpler indices of obesity such as WC, abdominal BIA, and 
DXA L2-L4 fat are useful proxies for TAAT. However, no 
simpler technique offers a good proxy for VAT. Thus to 
quantify VAT accurately, a sophisticated imaging technique 
such as MRI is warranted. 
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Discussion
This study shows that abdominal BIA ‘visceral fat level’, 
DXA L2-L4 fat, and WC (measured at either umbilical or 
midpoint waist) are all useful, simple proxy measures of 
TAAT. Conversely, none of the simpler measures of abdomi-
nal fat are good correlates of VAT, and hence to accurately 
assess VAT the expense of an MRI is warranted. This study 
provides little evidence to distinguish the usefulness of DXA 
L2-L4 fat, WC, and the abdominal BIA ‘visceral fat level’ as 
proxies for TAAT. However, in selecting a simpler method, 
the accuracy of each must be considered with its practical 
 advantages and disadvantages. 
Of the three BIA devices, the abdominal BIA device 
has a clear benefit over whole-body BIA devices for the 
measurement of abdominal fat, which was particularly evi-
dent in women. Correlations of the ‘visceral fat level’ from 
the abdominal BIA with MRI SAAT in men and women or 
MRI TAAT in women were significantly higher than those 
of the ‘visceral fat levels’ from BC-420 and MC-180 meas-
urements. In men, the MC-180 trunk fat and abdominal 
BIA trunk fat results are similar, though in women the 
 abdominal BIA trunk fat shows a significantly higher corre-
lation than the MC-180 trunk fat. Previously, results from 
whole-body BIA devices have shown poorer correlations 
with VAT than other simpler indices, particularly in obese 
individuals [18]. 
WC measurements are inexpensive and quick, although 
open to large observer error. In this study WC measurements 
were made under highly controlled conditions, with standard-
ised protocols and rigorous training leading to high precision 
[19]. However, in field situations, the accuracy of measure-
ments is likely to be more variable, particularly where more 
than one observer is responsible for making WC measure-
ments. It has previously been shown that inter-observer dif-
ferences are larger than intra-observer differences [20, 21]. 
For DXA, even though precision is high, expensive equip-
ment and, although very small, an additional X-ray exposure 
are required. 
These results confirm previous observations of absolute 
differences in the WC measurement obtained at different 
measurement sites, particularly in women [22–24]. However, 
the present study shows that both midpoint and umbilical WC 
measurements have similar relationships with MRI abdominal 
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